RNA medicines: potential for Germany as a business location

RNA refers to a large group of biomolecules that, following their success in Covid-19 vaccines, are believed to have great medical potential for prevention and therapy - and thus also significant economic importance.

Germany has the best chances of playing an important role here, as many companies and research institutes in this country are already working on this, according to a website posting.by the German pharma trade group VFA.

There are not only companies in Germany developing mRNA vaccines and other RNA-based medicines, but also suppliers of essential excipients required for their production. The developing companies either carry out the production of the actual medicines themselves or transfer it to contract manufacturers for individual manufacturing steps or the entire production.